BCM
MRK icon

BlueCrest Capital Management’s Merck MRK Stock Holding History

BlueCrest Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-63,300
Closed -$8.35M – 188
2024
Q1 		$8.35M Sell
63,300
-34,700
-35% -$4.28M 0.41% 40
2023
Q4 		$10.7M Buy
98,000
+19,700
+25% +$2.04M 0.41% 50
2023
Q3 		$8.06M Buy
78,300
+45,300
+137% +$4.88M 0.36% 50
2023
Q2 		$3.81M Buy
+33,000
New +$3.75M 0.13% 79

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlueCrest Capital Management's MRK Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Merck (MRK) in Q1 2024, closing a stake of 24,054 shares — an estimated $2.96M sold.

BlueCrest Capital Management first reported a position in MRK in Q4 2015 and held it in 16 quarters. The position peaked at $13M in Q4 2018. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 24,054 Merck shares in Q1 2024, an estimated $2.96M.
  • BlueCrest Capital Management first reported a position in Merck in Q4 2015 and held it in 16 quarters.
  • BlueCrest Capital Management's Merck position peaked at $13M in Q4 2018.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.